Benjamin Kuhnemuth
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
Journal: The Biochemical journal
Published: February 03, 2022
Tissue distribution of rIX-FP after intravenous application to rodents.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 27, 2020
Constitutive Expression of CCL22 Is Mediated by T Cell-Derived GM-CSF.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 03, 2020
CCL1 is a major regulatory T cell attracting factor in human breast cancer.
Journal: BMC cancer
Published: July 13, 2018
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes.
Journal: The Journal of experimental medicine
Published: February 12, 2017
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
Journal: Cancer letters
Published: November 02, 2015
Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.
Journal: Oncoimmunology
Published: October 16, 2015
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer.
Journal: Oncoimmunology
Published: September 29, 2015
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Journal: Endocrine-related cancer
Published: September 25, 2014
The role of CUX1 in antagonizing NF-κB signaling in TAMs.
Journal: Oncoimmunology
Published: February 11, 2014
Last Updated: 09/26/2026